PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
12-Mar-2020 Q BioMed Treats its First Patient in Commercial Setting Following Product Launch Q BioMed Inc
12-Mar-2020 Data visualisation tools developed by Zegami will be used by Oxford University for large cardiovascular clinical trials Zegami
11-Mar-2020 Bone Therapeutics announces 2019 full year results Bone Therapeutics
11-Mar-2020 Tiziana Life Sciences plc To Expedite Development of its Fully Human Anti-Interleukin-6-Receptor Monoclonal Antibody, a Potential Treatment of Certain Patients Infected with Coronavirus COVID-19 Tiziana Life Sciences plc
11-Mar-2020 BillionToOne has raised more than $32.5 million. The funding will be used to support the commercial expansion of UNITY™ to all US states BillionToOne
11-Mar-2020 First mental health trust joins collaboration of North East NHS organisations to drive forward digital health technology within the region Health Call
11-Mar-2020 Drugs alone cannot improve diabetes patients’ outcomes GlobalData
11-Mar-2020 Overcoming Data Collection and System Challenges in Real World Studies, Upcoming Webinar Presented Byr Cmed Cmed Clinical Research Services
10-Mar-2020 PharmiWeb Launches New Job Board for Pharma & Life Sciences in Australasia PharmiWeb
10-Mar-2020 Paradigm Shift in Angiography: Kinepict Medical Imaging Technology (KMIT) Receives US FDA 510(K) Clearance Kinepict Health Ltd.
10-Mar-2020 Freeline receives Orphan Drug Designation from the European Commission for FLT190 for the treatment of Fabry Disease Freeline
10-Mar-2020 PureTech Affiliate Gelesis Named One of the World’s Most Innovative Companies for 2020 by Fast Company PureTech
10-Mar-2020 Orgenesis Year-End Results, outlines business model and POCare strategy post-Masthercell sale Orgenesis
10-Mar-2020 Multi-million-pound impact investment in George Institute businesses to fast-track new treatments for the world’s biggest killers George Health
09-Mar-2020 Chemotherapy after surgery halves risk of rare kidney cancer coming back The Institute of Cancer Research
09-Mar-2020 Nanoform and Orion collaborate on next-generation drug development Nanoform
09-Mar-2020 Kancera provides an update on the development of the drug candidate KAND145 Kancera AB
09-Mar-2020 Hansa Biopharma announces long term follow-up data that demonstrates 2-year graft survival of 89% after imlifdase treatment and transplantation Hansa Biopharma AB
09-Mar-2020 Marinomed extends the range of Marinosolv® applications Marinomed Biotech AG
09-Mar-2020 SHIONOGI ANNOUNCES LAUNCH OF MULPLEO® (LUSUTROMBOPAG) IN THE UK, FOR THE TREATMENT OF SEVERE THROMBOCYTOPENIA IN ADULT PATIENTS WITH CHRONIC LIVER DISEASE UNDERGOING INVASIVE PROCEDURES Shionogi & Co., Ltd